<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">The interventional drugs in clinical trials can be classified based on their nature and complementary effect. In this regard, antivirals, antiparasitic drugs, immunosuppressors, immunomodulators, some well-known drugs, and nutritional drugs, in addition to combination therapies, are considered on ongoing studies for treatment, supportive care, or prevention. One can barely see the same mechanism of action inside and outside each group (
 <xref rid="tbl1" ref-type="table">Table 1</xref>), but many drugs are discovered for a specific disease and repurposed later for another disorder. 
 <xref rid="fig2" ref-type="fig">FigureÂ 2</xref> illustrates a general path that is being traversed by clinicians these days, although the results may not be desirable in some cases due to the emergent nature of SARS-CoV-2.
</p>
